Ozempic for Teens: What Parents Should Know

Can a teen take Ozempic? The short answer is no, not on-label. Ozempic is FDA-approved only for adults with type 2 diabetes. It has never been approved for anyone under 18, for any reason. If a doctor is weighing a GLP-1 medicine for a teen 12 or older, the FDA-approved choice is a different product. It has the same active drug but a different name: Wegovy injection. This guide explains the difference in plain language, so you can ask the right questions.

Ozempic and Wegovy are the same medicine, semaglutide, sold under two names for two different jobs. Knowing which is which helps you tell an on-label choice from an off-label one. Let's walk through it the way a pediatrician would.

Is Ozempic approved for teenagers?

No. Ozempic is FDA-approved only for adults with type 2 diabetes and two related adult heart and kidney conditions. Its label says its safety and effectiveness "have not been established in pediatric patients." So every use of Ozempic in a teen, whether for weight or for diabetes, is off-label.

Off-label does not mean illegal or automatically wrong. Doctors prescribe medicines off-label often, especially in pediatrics. But it does mean the FDA has not reviewed this exact use. That is why, when a teen truly needs a GLP-1 for weight, most doctors reach for the product the FDA did study in teens.

GLP-1 (a type of medicine that mimics a gut hormone to lower appetite and steady blood sugar) is the drug family we're talking about. Semaglutide is one GLP-1. Ozempic and Wegovy are two brand names for it.

Ozempic vs. Wegovy: same drug, different approval

Here is the piece that clears up most of the confusion. Both Ozempic and Wegovy contain semaglutide. Both are once-weekly shots you give under the skin. What differs is who they're approved for and what job they're approved to do.

For a teen who needs a GLP-1 for weight, the FDA-approved semaglutide is Wegovy injection, not Ozempic. You may also see semaglutide sold as a daily pill (brand names Rybelsus, and now Ozempic and Wegovy tablets too). None of those pills is approved for anyone under 18. The tablet is not a "kid-friendly" version. It is an adults-only form.

For more on the on-label teen product, see our companion guide, Wegovy for Teens.

When might a doctor consider a GLP-1 for a teen?

A doctor may consider weight-loss medicine for a teen who is 12 or older and living with obesity. It is always used alongside healthy eating and activity support, never instead of it. This follows the American Academy of Pediatrics (AAP).

The AAP's 2023 guideline for treating child and teen obesity is the current, in-force guidance. It advises pediatricians to offer weight-loss medicine to teens 12 and older who have obesity. In the guideline, obesity means a BMI at or above the 95th percentile for age and sex. And it says to use the medicine as an add-on to healthy-behavior and lifestyle treatment.

A few things worth knowing:

• Medicine is an add-on, not a last resort. The guideline says to offer it alongside lifestyle support, not only after a teen has "failed" diet and exercise.
• Lifestyle support still matters most. The AAP recommends intensive, family-based healthy-lifestyle programs for children 6 and older.
• The BMI threshold comes from the AAP guideline. Wegovy's own FDA approval simply says "12 years and older with obesity."

Wondering whether your teen fits this picture? We walk through it here: Is a GLP-1 Right for Your Teen?

How does semaglutide work, and how much weight do teens lose?

Semaglutide copies a natural gut hormone called GLP-1. That hormone helps you feel full sooner and stay full longer, so appetite drops. It also helps steady blood sugar. In the body, this usually leads to eating less without feeling starved.

The best study in teens is called STEP TEENS. It followed 201 teens (ages 12 to under 18) with obesity for 68 weeks. Everyone got nutrition and activity coaching; some also got semaglutide. Here is what it found, in plain terms:

• On average, teens taking semaglutide saw their BMI drop about 16%.
• About 3 in 4 teens taking semaglutide lost at least 5% of their body weight, compared with fewer than 1 in 5 who got the inactive shot (placebo).
• The teens who took the medicine also kept getting lifestyle support the whole time. The medicine was never used on its own.

One honest note: this study used the 2.4 mg dose of semaglutide (the Wegovy teen dose), not Ozempic. It is the strongest teen evidence we have, and it is evidence for medicine plus healthy habits together.

What are the side effects and safety concerns in teens?

The most common side effects are stomach-related: mainly nausea, vomiting, and diarrhea. In the teen study, about 6 in 10 teens on semaglutide had some stomach side effect, versus about 4 in 10 on placebo. These were mostly mild or moderate and short-lived (a couple of days), and they were worst while the dose was being slowly raised.

More serious but less common concerns from the teen study and the drug label include:

• Gallbladder problems (like gallstones) happened in about 4 in 100 teens on the medicine, and none on placebo.
• Pancreas inflammation, kidney problems from dehydration, low blood sugar, and serious allergic reactions are listed on the label as possible, though they were not seen often in the teen study.
• A slightly faster heart rate was measured on the medicine.
• Teens on the medicine were somewhat more likely than adults to have gallbladder issues, low blood pressure, and skin rashes. Some hair thinning was also reported.

Tell any surgeon, dentist, or anesthesiologist that your teen takes a GLP-1 before any procedure with sedation.

Growth, puberty, and muscle: what we monitor

Parents often ask whether this medicine could affect a growing teen's height or puberty. In the STEP TEENS study, researchers tracked growth and puberty (using Tanner stages, a standard measure of physical development) and did not find a meaningful effect over the 68 weeks. That is reassuring.

But 68 weeks is not the same as many years, and long-term teen data simply don't exist yet. That is why a pediatrician tracks height, weight, and puberty at regular visits, and why good nutrition and strength-building activity matter while a teen is losing weight. Semaglutide leads to more fat loss than lean-tissue loss (lean tissue includes muscle), but protecting muscle and healthy growth is still part of good care.

What Ozempic can't do on its own (lifestyle + supervision)

No GLP-1 is a standalone fix. In every teen study, the medicine was paired with healthy eating, activity, and regular check-ins, and that is how the AAP recommends using it. The medicine can quiet appetite; it cannot build lifelong habits or replace a supportive care team.

Two honest points to keep in mind:

• Weight tends to come back when the medicine stops. In the teen study, some BMI returned in the weeks after teens stopped the drug. That is the expected biology of a chronic-condition medicine. It is not a personal failure and not withdrawal. It simply means the benefit fades when the medicine does. Our guide on stepping down and stopping covers this.
• Supervision matters. These medicines work best inside an ongoing, doctor-led program that adjusts the plan over time.

How much does it cost, and does insurance cover it?

Costs and insurance coverage change often, so this page won't quote prices, because that would be out of date fast. For current details, see our companion pages on GLP-1 insurance coverage for teens and Wegovy cost for teens.

One thing worth knowing: these medicines are still used by only a small share of teens. The CDC reports that in 2023, about 1 in 200 U.S. teens with obesity was prescribed an FDA-approved obesity medicine, and most of those teens had severe obesity. So this is not a routine or first-line step. It is a supervised option for specific situations.

Questions to ask your teen's doctor

Bring these to your next visit. Good questions lead to better decisions:

• Is my teen a candidate for a GLP-1 medicine? Why or why not?
• If we consider medicine, would it be Wegovy injection (the FDA-approved teen option), or something off-label, and why?
• What healthy-habit support comes with it?
• What side effects should we watch for, and when should I call?
• Does anyone in our family have medullary thyroid cancer (MTC) or MEN 2?
• How will you track my teen's growth, puberty, and overall health?
• What happens if we decide to stop?

Not sure where to start? This guide can help you frame the conversation Is a GLP-1 Right for Your Teen?

How Blueberry Balance supports families

Blueberry Balance is our virtual, pediatrician-led program for teen weight health. We focus on supervised, whole-family care: honest education, healthy-habit coaching, and, when it's the right fit and medically appropriate, FDA-approved medication managed by a pediatrician. We prescribe the on-label teen product when medicine is part of the plan, and we keep nutrition, activity, and regular check-ins at the center.

We provide education and clinical care. We do not handle insurance paperwork, prior authorizations, or coverage checks. Your plan and pharmacy handle those.

Frequently asked questions

Can teenagers take Ozempic?

Not on-label. Ozempic is FDA-approved only for adults with type 2 diabetes. Any use in a teen is off-label. For teen weight management, the FDA-approved semaglutide is Wegovy injection, for ages 12 and up.

What's the difference between Ozempic and Wegovy for a teen?

They are the same drug, semaglutide, and both are weekly shots. Ozempic is approved only for adults (for diabetes). Wegovy injection is approved for weight management in teens 12 and older with obesity.

Is there an Ozempic pill for teens?

No. Semaglutide pills (Rybelsus, and Ozempic and Wegovy tablets) are approved only for adults. No oral semaglutide is approved for anyone under 18.

Is any GLP-1 approved for teens with type 2 diabetes?

Yes, but not Ozempic. For type 2 diabetes in kids 10 and older, some GLP-1 medicines are FDA-approved, such as Victoza (liraglutide) and Mounjaro (tirzepatide). No semaglutide product is approved for teen diabetes.

What about Zepbound?

Zepbound (tirzepatide) is approved only for adults. It is not an approved teen option and is out of scope for this guide.

How much weight do teens lose on semaglutide?

In the main teen study, teens' BMI dropped about 16% on average over 68 weeks, and about 3 in 4 lost at least 5% of their body weight, always paired with healthy-habit support.

Is it safe long-term?

We don't fully know yet. The longest good teen study ran about 16 months. Short-term it was reasonably well tolerated, but there is no long-term teen data, so ongoing doctor supervision matters.

What happens if my teen stops?

Some weight usually returns. That is the normal biology of the medicine, not a failure. Stopping should always be planned with your teen's doctor.

Sources

• American Academy of Pediatrics. Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2):e2022060640. doi:10.1542/peds.2022-060640
• Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity (STEP TEENS). N Engl J Med. 2022;387(24):2245-2257. doi:10.1056/NEJMoa2208601
• U.S. Food and Drug Administration. Ozempic (semaglutide) injection Prescribing Information, rev. 05/2026.
• U.S. Food and Drug Administration. Wegovy (semaglutide) injection Prescribing Information, rev. 06/2026.
• Centers for Disease Control and Prevention. Antiobesity Medication Prescriptions Among U.S. Adolescents. MMWR Morb Mortal Wkly Rep. 2025;74(20):335-341. doi:10.15585/mmwr.mm7420a1
• U.S. Food and Drug Administration. Victoza (liraglutide) injection Prescribing Information, rev. 10/2025, §1 (pediatric type 2 diabetes, ages 10 and older).
• U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection Prescribing Information, rev. 04/2026, §1, §8.4 (pediatric type 2 diabetes, ages 10 and older).
• U.S. Food and Drug Administration. Rybelsus and Ozempic (semaglutide) tablets, shared Prescribing Information, rev. 01/2026; Wegovy (semaglutide) tablets, §8.4 (oral semaglutide, adults only).
• U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information, rev. 04/2026, §8.4 (adults only).

This article is for general education and is not medical advice. It is not a substitute for care from your teen's doctor. Always talk with a qualified health professional before starting, changing, or stopping any medicine. If your teen has severe belly pain, trouble breathing, signs of a serious allergic reaction, or another medical emergency, seek in-person care right away.